BioRestorative Therapies Announces Participation in Adipose Tissue Biology Keystone Conference Series

JUPITER, Fla., Jan. 14, 2013 /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTCBB: BRTX), a life sciences company focused on adult stem cell (non-embryonic) based cellular therapies for various personal medical applications, announced today that it has been invited to present at the Adipose Tissue Biology conference of the Keystone Symposia conference series on January 30, 2013. The Conference will be held at the Keystone Resort in Keystone, Colorado from January 27, 2013 to February 1, 2013.

BRT Chief Scientist, Francisco Silva, will be presenting the Company's research on Human Metabolically Active Brown Adipose Tissue Derived Stem Cells, which will be readily available to all organizers, speakers, and attendees of the conference. This research is a result of the scientific work BRT has been performing pursuant to its ThermoStem™ Program which focuses on treatments for metabolic disorders (diabetes, heart disease, etc.) and obesity and uses brown fat stem cells.

The Keystone Symposia on Molecular and Cellular Biology is a non-profit organization based in Silverthorne, Colorado that was founded in 1972. Keystone has shown unrelenting and uninhibited support for the advancement of biomedical and life sciences worldwide having convened 50-60 conferences per year across five continents. The goal of this conference is to engage researchers from diverse fields to take basic discoveries in adipocyte biology to the next level, including a deeper understanding of the etiology of type 2 diabetes and correlated diseases such as cancer, dementia and asthma through the conferences joint meeting sessions.

About BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. ("BRT") develops medical procedures using cell and tissue protocols, primarily involving adult stem cells (non-embryonic), and allowing patients to undergo minimally invasive cellular-based treatments. BRT is developing the following scientific initiatives: Our brtxDISC™ Program (Disc Implanted Stem Cells) offers a non-surgical treatment for bulging and herniated discs and addresses the gap between non-invasive and invasive back procedures. Our ThermoStem™ Program focuses on treatments for metabolic disorders (diabetes, heart disease, etc.) and obesity and uses brown fat stem cells. Initial research indicates that increased amounts of brown fat in the body may be responsible for additional caloric burning as well as reduced glucose and lipid levels in the body. The Company also offers plant stem cell-based facial creams and products under the Stem Pearls® brand at www.stempearls.com.

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks, including those set forth in the Company's Form 10-K filed with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements.

Investor Contacts:
KCSA Strategic Communications
Philip Carlson / Josh Dver
+1 212.896.1233 / +1 212.896.1239
[email protected] / [email protected]

SOURCE BioRestorative Therapies, Inc.